Diaziquone

This classification denotes an ethylenimine compound with the molecular formula C16H20N4O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FQL5EUP13W, chemically known as 3,6-diaziridinyl-2,5-bis(carboethoxyamino)-1,4-benzoquinone but more generally known as diaziquone, which bears US NIH Compound Identifier 42616. European Medicines Agency schedules Diaziquone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07070MIG. The term DIAZIQUONE is an International Non-Proprietary Name. DIAZIQUONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule diaziquone under HS 29339990 and SITC 51577. As of Q4 2014, DIAZIQUONE remains US FDA's Preferred Term for this commodity. Diaziquone bears US NLM identifiers UMLS ID C0113600 and NCI Concept Code C1363. SMILES: O=C1C(=C(NC(=O)OCC)C(=O)C(=C1NC(=O)OCC)N1CC1)N1CC1.